血清幽门螺杆菌抗体联合胃蛋白酶原检测在胃癌和癌前病变筛查中的作用

摘要
图/表
参考文献(15)
相关文章 (15)

全文: PDF (0 KB) HTML (31 KB)
输出: BibTeX | EndNote (RIS)

摘要目的探讨血清幽门螺杆菌（Hp）抗体联合胃蛋白酶原（PG）检测在胃癌和癌前病变筛查中的作用。方法选取2019年6月～2020年1月我院收治的440 例胃部疾病患者作为研究对象进行回顾性分析，将其纳入胃部疾病组，另选取同期我院的112 例健康体检人员作为健康对照组。统计分析两组人员的Hp 感染情况、血清PGⅠ、PGⅡ水平、PGR。结果胃部疾病各组（胃癌组、胃溃疡组、萎缩性胃炎组、浅表性胃炎组）与健康对照组的Hp 阳性率、Hp 阴性率比较，差异均无统计学意义（P＞0.05）。胃溃疡组的血清PGⅠ水平高于健康对照组（P＜0.05）。胃癌组、萎缩性胃炎组的血清PGⅠ水平均低于健康对照组（P＜0.05）。胃癌组、胃溃疡组、萎缩性胃炎组的血清PGⅡ水平均高于健康对照组，PGR 均低于健康对照组（P＜0.05）。浅表性胃炎组与健康对照组的血清PGⅠ、PGⅡ、PGR 比较，差异均无统计学意义（P＞0.05）。胃癌组、胃溃疡组、萎缩性胃炎组、浅表性胃炎组、健康对照组Hp 阳性和阴性人员的血清PGⅠ、PGⅡ、PGR 比较，差异均无统计学意义（P＞0.05）。结论在胃癌和癌前病变筛查中，检测Hp 抗体和PG，具有积极的临床诊断价值，值得推广应用。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	黎杨杨
	林裕锋
	陈冬玲

关键词 ：胃癌, 癌前病变, 血清幽门螺杆菌抗体, 胃蛋白酶原, 筛查

Abstract：Objective To investigate the role of serum Helicobacter pylori (Hp) antibody combined with pepsinogen(PG) detection in the screening of gastric cancer and precancerous lesions. Methods A total of 440 cases of patients with gastric diseases in our hospital From June 2019 to January 2020 were selected as gastric disease group, and 112 cases of healthy people in our hospital were selected as control group. The Hp infections, serum PGⅠ, PGⅡlevels and PGR of the two groups were statistically analyzed. Results Comparison of Hp positive rates and HP negative rates between gastric disease groups (gastric cancer group, gastric ulcer group, atrophic gastritis group, superficial gastritis group) and healthy control group showed no statistically significant differences (P＞0.05). The serum PGⅠlevel of patients in the gastric ulcer group was higher than that of healthy control group (P＜0.05). The serum PGⅠlevel of gastric cancer group and atrophic gastritis group was lower than that of the healthy control group (P＜0.05). The serum PGⅡlevel of gastric cancer group, gastric ulcer group and atrophic gastritis group was higher than that of healthy control group, while the PGR level was lower than that of healthy control group (P＜0.05). There were no significant differences in serum PGⅠ, PGⅡlevels and PGR between the superficial gastritis group and the healthy control group (P＞0.05).There were no statistically significant differences in serum PGⅠ, PGⅡlevels and PGR between Hp positive and Hp negative subjects in gastric cancer group, gastric ulcer group, atrophic gastritis group, superficial gastritis group and healthy control group (P＞0.05). Conclusion In the screening of gastric cancer and precancerous lesions, the detection of Hp antibody and PG has positive clinical diagnostic value and is worthy of promotion.

Key words： Gastric cancer Precancerous lesions Serum Helicobacter pylori antibody Pepsinogen Screening

基金资助:广东省阳江市医疗卫生类科技计划项目（社发[2017]22）

引用本文:

黎杨杨;林裕锋;陈冬玲. 血清幽门螺杆菌抗体联合胃蛋白酶原检测在胃癌和癌前病变筛查中的作用[J]. 中国当代医药, 2020, 27(25): 187-189转193.
LI Yang-yang; LIN Yu-feng ;CHEN Dong-ling. Role of Helicobacter pylori serum antibody combined with pepsinogen detection in screening of gastric cancer and precancerous lesions. 中国当代医药, 2020, 27(25): 187-189转193.

链接本文:

https://www.dangdaiyiyao.com/CN/ 或 https://www.dangdaiyiyao.com/CN/Y2020/V27/I25/187